Hoylu_Logo_2019.png
Hoylu AB (publ) carries out a SEK 15 million convertible loan notes issue
January 24, 2022 17:30 ET | Hoylu AB
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA...
HyberCell.jpg
HiberCell Closes $67.4 Million Series B Financing and Secures $30 Million Debt Facility from Hercules Capital
May 19, 2021 08:00 ET | HiberCell
Proceeds to advance pipeline of clinical product candidates focused on preventing cancer relapse and metastasis NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) -- HiberCell, a biotechnology company...
20170511-Liberty200.jpg
Liberty Gold Announces Closing of the Sale of the Halilağa Porphyry Copper Gold Deposit in Turkey, and Receipt of US$6,000,000 Cash Payment
August 12, 2020 13:00 ET | Liberty Gold Corp.
VANCOUVER, British Columbia, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (LGD-TSX) (“Liberty Gold” or the “Company”) is pleased to announce the closing of sale of its 40% interest in the...
AlluxioLogo_Vertical_Blue (3).jpg
Alluxio Expands Funding to $23M to Increase Investment in Hybrid Cloud Data Orchestration
April 16, 2020 08:00 ET | Alluxio, Inc.
SAN MATEO, Calif., April 16, 2020 (GLOBE NEWSWIRE) -- Alluxio, the developer of open source cloud data orchestration software, today announced it has extended its Series B financing to $15.5...
20170511-Liberty200.jpg
Liberty Gold Announces Receipt of US$4,000,000 and Amended Definitive Agreement to Sell the Halilağa Porphyry Copper Gold Deposit in Turkey
November 18, 2019 06:00 ET | Liberty Gold Corp.
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (LGD-TSX) (“Liberty Gold” or the “Company”) is pleased to announce it has received a US$4,000,000 nonrefundable...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Dr. Henry Ji to Participate In Financing Expert Panel at East/West CEO Conference
January 04, 2019 07:00 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced today that Dr. Henry Ji, Chairman and CEO, will participate in the East/West CEO...